Over 18 years old. Able to and provide written informed consent to participate. If female: postmenopausal or if a woman of childbearing potential using a suitable contraception. If male, using a suitable contraceptive method for the duration of the study. Radiologically suspected or pathologically confirmed benign or malignant renal masses, as determined by standard clinical practice. Capable of undergoing a minimum of one study visit.
| The presence of any of the following will preclude participation, as determined by the delegated investigator:Contraindication or inability to tolerate MRI. Pregnant or actively breastfeeding woman. If using an intrauterine contraceptive device as a method of contraception, the device should be MRI safe at 3 T (researcher to confirm). Clinically significant cardiac, pulmonary or neurological diseases as determined by the investigators. Laboratory abnormalities that may impact on the study results. Any other significant medical or psychiatric history rendering the subject ineligible as deemed by the investigators.
|